Abiopharma

Employee Stock Option/ Share Scheme: GRANT OF SHARE OPTIONS PURSUANT TO THE CREATIVE SHARE OPTION SCHEME (2019)

General Announcement: PRICING OF OFFERING S$110M 2.50% NOTES DUE 2030 UNDER S$3B MMTN PROGRAMME OF GLL IHT PTE. LTD.

Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Merck’s Tulisokibart Met Primary and Key Secondary Endpoints in the Phase 3 ATLAS-UC Induction-only Study in Patients With Moderately to Severely Active Ulcerative Colitis (UC)

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Change in Interest of Director

Share Buy Back - Daily Share Buy-Back Notice: Daily Share Buy-Back Notice

DHT Holdings, Inc. announces the results of the 2026 annual meeting of shareholders

Mandatory Cash Dividend/ Distribution:

Disclosure of Interest/ Changes in Interest of Director/ Chief Executive Officer: Disclosure of Interest/ Change in Interest of Director

MOGU Announces Unaudited Financial Results for the Six Months Ended March 31, 2026 and Fiscal Year 2026